The updated global DVA 6.0 includes new data from the 2019/2020 ATU Study, simplified, intuitive navigation, and clear links to the connection between the Detached Debbie patient profile and Brintellix data. The update is based on feedback from sales affiliates and physician's interviews. In addition to solidifying the links between the data and the Detached Debbie profile for physicians, this podcast episode offers practical tips for navigating the newly enhanced DVA. New sections offer clear data points to increase affiliate confidence when speaking to Dr. Mood, Dr. Function, and the high prescriber, Dr. Progressive.
Key Takeaways:
[3:40] The Feel, Think, Do section of the DVA provides a direct connection between a patient quote and the contextual data relevant to how Brintellix works to achieve treatment goals.
[7:23] Using the DVA to demonstrate the correlation between the relevant data and the symptoms of Detached Debbie when speaking with Dr. Mood.
[8:58] How to use the color-coded quotes to approach a conversation about Brintellix's efficacy in treating cognitive symptoms with Dr. Function.
[10:56] The Patient Population section helps high prescribers, aka Dr. Progressives, who may be ready to move beyond the Detached Debbie profile better understand the benefits of Brintellix based on new data from trauma studies.
[12:50] The Dosing section communicates the medical rationale behind increasing the dose to 20mg based on the Flexible Dose study.
[15:59] The Mode of Action chapter helps doctors understand how different doses affect the neurotransmitter systems and reinforced the Brintellix story.
Resources:
